Takhzyro 300 mg (Lanadelumab SOLUTION) 300 MG

TAKHZYRO 300 MG is a subcutaneous solution containing lanadelumab, used for managing hereditary angioedema (HAE) attacks. This medication helps reduce the frequency of swelling episodes in adults and children aged 12 years and older.

Strength

300 MG

Pack Size

2ML

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TAKHZYRO 300 MG is primarily used for the prevention of hereditary angioedema (HAE) attacks. HAE is a rare genetic condition characterized by recurrent swelling in various parts of the body. Lanadelumab, the active ingredient, works by targeting specific proteins involved in the inflammatory process, thereby reducing the frequency and severity of HAE episodes. Patients often wonder, 'What is TAKHZYRO used for?' and the answer lies in its ability to manage and prevent these debilitating attacks.

Side Effects

Common effects of TAKHZYRO 300 MG may include injection site reactions such as redness, swelling, or pain. Some individuals might experience headache, fatigue, or dizziness. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

TAKHZYRO 300 MG should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients with a history of allergic reactions to lanadelumab or any of the ingredients should avoid using this medication. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

TAKHZYRO 300 MG may interact with other medications, including those that affect the immune system or blood clotting. It is advisable to inform your healthcare provider about all medications, supplements, and herbal products you are currently taking. Alcohol and certain foods may also interact with this medication, so it is important to discuss any potential interactions with a healthcare professional.

Frequently Asked Questions

TAKHZYRO is used to prevent hereditary angioedema (HAE) attacks in adults and children aged 12 years and older.

TAKHZYRO is administered as a subcutaneous injection, typically self-administered or given by a healthcare provider.

Common side effects include injection site reactions, headache, fatigue, and dizziness.

Yes, TAKHZYRO is approved for use in children aged 12 years and older.

TAKHZYRO should be stored in the refrigerator between 2°C and 8°C (36°F and 46°F) and protected from light.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.